Is Apple Stock Undervalued or Overvalued?
For many years, Apple (NASDAQ:AAPL) was just about the perfect…
Sell
18
PHBBF Quote, Financials, Valuation and Earnings
Last price:
$1.93
Seasonality move
:
0%
Day range:
$1.93 - $1.93
52-week range:
$1.93 - $1.93
Dividend yield:
1.46%
P/E ratio:
--
P/S ratio:
1.44x
P/B ratio:
1.56x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$2.5B
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for PHBBF
Aug 27
2025
Most recent earnings per share
$0.04
Beat by $0.04
(Mar 31/2023)
Consensus Estimate
--
(Mar 31/2023)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PHBBF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2023 | Q1 | -- | $398M | $0.04 | -- | -- |
| 12/31/2022 | Q4 | -- | $402.5M | $0.05 | -- | -- |
| 09/30/2022 | Q3 | -- | $404.1M | $0.05 | -- | -- |
| 06/30/2022 | Q2 | -- | $383M | $0.04 | -- | -- |
| 03/31/2022 | Q1 | -- | $330.8M | $0.03 | -- | -- |
| 12/31/2021 | Q4 | -- | $334.7M | $0.08 | -- | -- |
| 09/30/2021 | Q3 | -- | $311.3M | $0.06 | -- | -- |
| 06/30/2021 | Q2 | -- | $278M | $0.04 | -- | -- |
| 03/31/2021 | Q1 | -- | $229.6M | $0.03 | -- | -- |
| 12/31/2020 | Q4 | -- | $233.4M | $0.05 | -- | -- |
| 09/30/2020 | Q3 | -- | $201.2M | $0.04 | -- | -- |
| 06/30/2020 | Q2 | -- | $174M | $0.04 | -- | -- |
| 03/31/2020 | Q1 | -- | $137.4M | $0.01 | -- | -- |
| 12/31/2019 | Q4 | -- | $160.5M | $0.03 | -- | -- |
| 09/30/2019 | Q3 | -- | $141.1M | $0.02 | -- | -- |
| 06/30/2019 | Q2 | -- | $128M | $0.02 | -- | -- |
| 03/31/2019 | Q1 | -- | $113.1M | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | $126.2M | $0.02 | -- | -- |
| 09/30/2018 | Q3 | -- | $112.4M | $0.02 | -- | -- |
| 06/30/2018 | Q2 | -- | $108.1M | $0.01 | -- | -- |
| 03/31/2018 | Q1 | -- | $91.5M | $0.01 | -- | -- |
| 12/31/2017 | Q4 | -- | $102.5M | $0.01 | -- | -- |
Pharmaron Beijing Earnings Questions
-
How Much did Pharmaron Beijing Generate in Revenue Last Quarter?
Pharmaron Beijing reported $398M worth of top line sales in its most recent quarter.
-
Did Pharmaron Beijing Beat Earnings Last Quarter?
Pharmaron Beijing announced earnings per share of $0.04 which represents a beat of analyst forecast a -- per share.
-
Is Pharmaron Beijing Profitable?
Pharmaron Beijing reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Pharmaron Beijing EPS Next Year?
Pharmaron Beijing's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Pharmaron Beijing's Earnings Date?
Pharmaron Beijing's next earnings date is August 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Palo Alto Networks Stock Be in 5 Years?
You know those companies that just refuse to slow down…
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
84
SBET alert for May 28
SharpLink Gaming [SBET] is down 17.58% over the past day.
Buy
58
TNXP alert for May 28
Tonix Pharmaceuticals Holding [TNXP] is down 5.54% over the past day.
Sell
37
ATS alert for May 28
ATS [ATS] is down 1.31% over the past day.
